Research Output per year
Research Outputs
2019
Emergence of microRNAs as key players in cancer cell metabolism
Subramaniam, S., Jeet, V., Clements, J. A., Gunter, J. H. & Batra, J., 1 Sep 2019, In : Clinical Chemistry. 65, 9, p. 1090-1101 12 p.Research output: Contribution to journal › Review article
10
Citations
(Scopus)
Interleukin (IL)-22 from IL-20 subfamily of cytokines induces colonic epithelial cell proliferation predominantly through ERK1/2 pathway
Moniruzzaman, M., Wang, R., Jeet, V., McGuckin, M. A. & Hasnain, S. Z., 15 Jul 2019, In : International Journal of Molecular Sciences. 20, 14, p. 1-17 17 p., 3468.Research output: Contribution to journal › Article
Open Access
File
2
Citations
(Scopus)
1
Downloads
(Pure)
MicroRNA-3162-5p-mediated crosstalk between Kallikrein family members including prostate-specific antigen in prostate cancer
Australian Prostate Cancer BioResource, Mating, F., Jeet, V., Srinivasan, S., Cristino, A. S., Panchadsaram, J., Clements, J. A. & Batra, J., Jun 2019, In : Clinical Chemistry. 65, 6, p. 771-780 10 p.Research output: Contribution to journal › Article
3
Citations
(Scopus)
2018
A biomarker and a therapeutic target: investigating the role of glypican-1 in prostate cancer
Jeet, V., Rockstroh, A., Yeh, M-C., Campbell, D. H., Walsh, B. J., Russell, P. J. & Nelson, C. C., Aug 2018, In : BJU International. 122, S2, p. 36-37 2 p., 084.Research output: Contribution to journal › Meeting abstract
Allele specific regulation of PDK1 by miRNAs in prostate cancer
Subramaniam, S., Jeet, V., Walpole, C., Nelson, C. C., Gunter, J. H., Clements, J. A. & Batra, J., Aug 2018, In : BJU International. 122, S2, p. 36-36 1 p., 083.Research output: Contribution to journal › Meeting abstract
A plasma biomarker panel of four microRNAs for the diagnosis of prostate cancer
Australian Prostate Cancer BioResource, Matin, F., Jeet, V., Moya, L., Selth, L. A., Chambers, S., Clements, J. A. & Batra, J., Aug 2018, In : BJU International. 122, S2, p. 29-29 1 p., 066.Research output: Contribution to journal › Meeting abstract
3
Citations
(Scopus)
A Plasma biomarker panel of four MicroRNAs for the diagnosis of prostate cancer
Australian Prostate Cancer BioResource, Matin, F., Jeet, V., Moya, L., Selth, L. A., Chambers, S., Clements, J. A. & Batra, J., 27 Apr 2018, In : Scientific Reports. 8, 15 p., 6653.Research output: Contribution to journal › Article
Open Access
File
16
Citations
(Scopus)
Targeted beta therapy of human prostate cancer in vivo with Lu-177 labelled MIL-38 antibody against glypican-1 (GPC-1)
Yeh, M-C., Tse, B. W. C., Fletcher, N. L., Huston, Z. H., Stewart, C., Sokolowski, K., Jeet, V., Wissmueller, S., Thurecht, K. J., Campbell, D. H., Walsh, B. J., Nelson, C. C. & Russell, P. J., Aug 2018, In : BJU International. 122, S2, p. 34-35 2 p., 078.Research output: Contribution to journal › Meeting abstract
2017
MicroRNAs in HPV associated cancers: small players with big consequences
Satapathy, S., Batra, J., Jeet, V., Thompson, E. W. & Punyadeera, C., 3 Jul 2017, In : Expert Review of Molecular Diagnostics. 17, 7, p. 711-722 12 p.Research output: Contribution to journal › Review article
12
Citations
(Scopus)
PDK1 dependent aerobic glycolysis and tumorigenesis in prostate cancer is regulated by miRNAs in an allele dependent manner
Subramaniam, S., Jeet, V., Walpole, C., Nelson, C. C., Gunter, J. H., Clements, J. A. & Batra, J., Aug 2017, In : BJU International. 120, S1, p. 19-19 1 p., 014.Research output: Contribution to journal › Meeting abstract
2016
Comprehensive profiling of androgen signalling and energy and lipid metabolism highlights heterogeneity of prostate cancer cell lines
Sadowski, M. C., Mcpherson, S. J., Rockstroh, A., Soekmadji, C., Tevz, G., Gunter, J. H., Jeet, V. & Nelson, C. C., Aug 2016, In : BJU International. 118, S1, p. 34-34 1 p., 085.Research output: Contribution to journal › Meeting abstract
Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets
Chiang, M-C., Tullett, K. M., Lee, Y. S., Idris, A., Ding, Y., McDonald, K. J., Kassianos, A., Rojas, I. M. L., Jeet, V., Lahoud, M. H. & Radford, K. J., Feb 2016, In : European Journal of Immunology. 46, 2, p. 329-339 11 p.Research output: Contribution to journal › Article
20
Citations
(Scopus)
Glypican-1: a new biomarker for the detection of prostate cancer
Yeh, M-C., Jeet, V., Wissmueller, S., Campbell, D. H., Walsh, B. J., Nelson, C. C. & Russell, P. J., Aug 2016, In : BJU International. 118, S1, p. 27-27 1 p., 038.Research output: Contribution to journal › Meeting abstract
Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer
Tevz, G., McGrath, S., Demeter, R., Magrini, V., Jeet, V., Rockstroh, A., McPherson, S., Lai, J., Bartonicek, N., An, J., Batra, J., Dinger, M. E., Lehman, M. L., Williams, E. D. & Nelson, C. C., 15 Jan 2016, In : Molecular and Cellular Endocrinology. 420, p. 159-168 10 p.Research output: Contribution to journal › Article
8
Citations
(Scopus)
MicroRNAs in plasma: potential minimally invasive biomarkers for the detection of aggressive prostate cancer
Matin, F., Moya, L., Jeet, V., Clements, J. & Batra, J., Aug 2016, In : BJU International. 118, S1, p. 30-30 1 p., 046.Research output: Contribution to journal › Meeting abstract
11
Citations
(Scopus)
MicroRNA theranostics in prostate cancer precision medicine
Matin, F., Jeet, V., Clements, J. A., Yousef, G. M. & Batra, J., Oct 2016, In : Clinical Chemistry. 62, 10, p. 1318-1333 16 p.Research output: Contribution to journal › Review article
26
Citations
(Scopus)
More than a biomarker: exploring the role of glypican-1 as a new therapeutic target for prostate cancer
Jeet, V., Yeh, M-C., Campbell, D. H., Walsh, B. J., Russell, P. J. & Nelson, C. C., Aug 2016, In : BJU International. 118, S1, p. 28-28 1 p., 040.Research output: Contribution to journal › Meeting abstract
2015
Impeding the adaptive response of prostate cancer to androgen targeted therapies with relaxin receptor antagonist
Tevz, G., Hossain, A. M., Bock, N., Jeet, V., Bathgate, R. A., Williams, E. D., Lehman, M., Hutmacher, D. W., Wade, J. D. & Nelson, C. C., Aug 2015, In : BJU International. 116, S1, p. 36-36 1 p., 075.Research output: Contribution to journal › Meeting abstract
9
Citations
(Scopus)
Investigating the role of a potential angiogenic target, YKL40, for the treatment of metastatic prostate cancer
Jeet, V., Rockstroh, A., Lehman, M. & Nelson, C. C., Aug 2015, In : BJU International. 116, S1, p. 33-33 1 p., 063.Research output: Contribution to journal › Meeting abstract
2014
Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells
Jeet, V., Tevz, G., Lehman, M., Hollier, B. & Nelson, C., Oct 2014, In : Endocrine-Related Cancer. 21, 5, p. 723-737 15 p.Research output: Contribution to journal › Article
Open Access
File
14
Citations
(Scopus)
8
Downloads
(Pure)
Therapeutic options for metastatic castration resistant prostate cancer: has the situation improved?
Jeet, V., 2014, Advances in Drug Resistance Research. Morais, C. (ed.). New York: Nova Science Publishers, p. 137-154 15 p. (Public health in the 21st century).Research output: Chapter in Book/Report/Conference proceeding › Chapter
2013
YKL40as a therapeutic target for the treatment of metastatic Prostate Cancer
Jeet, V. & Nelson, C. C., Aug 2013, In : BJU International. 112, S1, p. 45-45 1 p., 25038.Research output: Contribution to journal › Meeting abstract
20
Citations
(Scopus)
2012
Cross-presentation by human dendritic subsets depends on the type of antigen and exogenous stimuli
McDonald, K., Kassianos, A., Jeet, V., Ju, X., Ding, Y., Hart, D. & Radford, K., May 2012, In : Molecular Immunology. 51, 1, p. 28-28 1 p.Research output: Contribution to journal › Meeting abstract
Targeting Aurora Kinases: A novel approach to curb the growth & chemoresistance of androgen refractory prostate cancer
Jeet, V., Russell, P. J., Verma, N. D. & Khatri, A., 1 Feb 2012, In : Current Cancer Drug Targets. 12, 2, p. 144-163 20 p.Research output: Contribution to journal › Article
4
Citations
(Scopus)
2010
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
Jongbloed, S. L., Kassianos, A. J., McDonald, K. J., Clark, G. J., Ju, X., Angel, C. E., Chen, C-J. J., Dunbar, P. R., Wadley, R. B., Jeet, V., Vulink, A. J. E., Hart, D. N. J. & Radford, K. J., 7 Jun 2010, In : Journal of Experimental Medicine. 207, 6, p. 1247-1260 14 p.Research output: Contribution to journal › Article
Open Access
File
637
Citations
(Scopus)
6
Downloads
(Pure)
Modeling prostate cancer: a perspective on transgenic mouse models
Jeet, V., Russell, P. J. & Khatri, A., Mar 2010, In : Cancer and Metastasis Reviews. 29, 1, p. 123-142 20 p.Research output: Contribution to journal › Review article
33
Citations
(Scopus)
2008
Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer
Jeet, V., Ow, K., Doherty, E., Curley, B., Russell, P. J. & Khatri, A., 1 Apr 2008, In : Prostate. 68, 5, p. 548-562 15 p.Research output: Contribution to journal › Article
9
Citations
(Scopus)